Abbvie plans to lift $2 billion cap on deals

[ad_1] © Reuters. FILE PHOTO: A sign stands outside a Abbvie facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/ (Reuters) – Abbvie will lift a self-imposed $2 billion limit on acquisitions and mergers placed following a $63 billion deal for Botox maker Allergan (NYSE:) in 2020 that shot up its debt, the company’s … Read more